Hartman Institute for Therapeutic Organ Regeneration

Human organoid models to study SARS-CoV-2 infection.

TitleHuman organoid models to study SARS-CoV-2 infection.
Publication TypeJournal Article
Year of Publication2022
AuthorsHan Y, Yang L, Lacko LA, Chen S
JournalNat Methods
Volume19
Issue4
Pagination418-428
Date Published2022 Apr
ISSN1548-7105
KeywordsAdult, COVID-19, Humans, Organoids, Pandemics, Pluripotent Stem Cells, SARS-CoV-2
Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the deadliest pandemics in history. SARS-CoV-2 not only infects the respiratory tract, but also causes damage to many organs. Organoids, which can self-renew and recapitulate the various physiology of different organs, serve as powerful platforms to model COVID-19. In this Perspective, we overview the current effort to apply both human pluripotent stem cell-derived organoids and adult organoids to study SARS-CoV-2 tropism, host response and immune cell-mediated host damage, and perform drug discovery and vaccine development. We summarize the technologies used in organoid-based COVID-19 research, discuss the remaining challenges and provide future perspectives in the application of organoid models to study SARS-CoV-2 and future emerging viruses.

DOI10.1038/s41592-022-01453-y
Alternate JournalNat Methods
PubMed ID35396481
PubMed Central ID349323
Grant ListR01 DK124463 / DK / NIDDK NIH HHS / United States
DP3 DK111907 / DK / NIDDK NIH HHS / United States
R01 DK116075 / DK / NIDDK NIH HHS / United States
R01 DK119667 / DK / NIDDK NIH HHS / United States
F32 HD096810 / HD / NICHD NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065